1 BTC
=
- USD
Phreesia, Inc.
As of May 30, 2026 at 24:05 UTC
Chart
About Phreesia, Inc.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
Market Statistics
Trading Metrics
How to Buy PHR
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy PHR
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesRosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Veritone, Inc. (VERI), where the company allegedly made false statements about revenue and financial performance, maintained deficient internal controls, and will need to restate financial statements. The lead plaintiff deadline is July 20, 2026. Similar notices were issued for Phreesia, Inc. (PHR) and Stellantis N.V. (STLA).
Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Phreesia, Inc. (PHR), where investors who purchased stock between May 8, 2025 and March 30, 2026 may be entitled to compensation. The lawsuit alleges Phreesia made false statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Additional class actions are mentioned for Veritone, Inc. (VERI) and Stellantis N.V. (STLA). The lead plaintiff deadline for the Phreesia case is July 13, 2026.
Phreesia Inc. faces a securities fraud class action lawsuit after the company announced significantly lowered revenue growth projections for fiscal 2027 on March 30, 2026, citing macroeconomic factors and weaker pharmaceutical marketing commitments. The stock fell 26.6% following the announcement. Shareholders who purchased stock between May 8, 2025 and March 30, 2026 have until July 13, 2026 to file a lead plaintiff motion.
A securities fraud class action lawsuit has been filed against Phreesia Inc. after the company announced significantly lowered revenue growth projections for fiscal 2027 on March 30, 2026, citing macroeconomic factors and weaker pharmaceutical marketing commitments. The stock fell 26.6% following the announcement. Investors who purchased shares between May 8, 2025 and March 30, 2026 have until July 13, 2026 to file a lead plaintiff motion.
The Schall Law Firm is seeking investors who purchased Phreesia, Inc. securities between May 8, 2025 and March 30, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about its long-term growth outlook and fiscal year 2027 projections, particularly regarding pharmaceutical marketing commitments as a growth driver for its Network Solutions segment. Investors who suffered losses are encouraged to contact the firm before July 13, 2026.